Recent genomic studies identified the NF-κB, JAK/STAT, PI3K/mTOR, MAPK and T cell receptor signaling pathways to be involved in the pathogenesis of CTCL [22, 23]. Here, NFKB1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.